JP2022510700A5 - - Google Patents
Info
- Publication number
- JP2022510700A5 JP2022510700A5 JP2021532119A JP2021532119A JP2022510700A5 JP 2022510700 A5 JP2022510700 A5 JP 2022510700A5 JP 2021532119 A JP2021532119 A JP 2021532119A JP 2021532119 A JP2021532119 A JP 2021532119A JP 2022510700 A5 JP2022510700 A5 JP 2022510700A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1819936.4A GB201819936D0 (en) | 2018-12-06 | 2018-12-06 | Therapeutic methods |
| GB1819936.4 | 2018-12-06 | ||
| GBGB1904341.3A GB201904341D0 (en) | 2019-03-28 | 2019-03-28 | Therapeutic methods |
| GB1904341.3 | 2019-03-28 | ||
| PCT/GB2019/053456 WO2020115500A1 (en) | 2018-12-06 | 2019-12-06 | Usp19 inhibitors for use in therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022510700A JP2022510700A (ja) | 2022-01-27 |
| JPWO2020115500A5 JPWO2020115500A5 (https=) | 2023-01-11 |
| JP2022510700A5 true JP2022510700A5 (https=) | 2023-01-11 |
Family
ID=68887434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532119A Pending JP2022510700A (ja) | 2018-12-06 | 2019-12-06 | 治療において使用するｕｓｐ１９阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220016115A1 (https=) |
| EP (1) | EP3890737B1 (https=) |
| JP (1) | JP2022510700A (https=) |
| KR (1) | KR20210100127A (https=) |
| CN (1) | CN113395965A (https=) |
| AU (1) | AU2019393161A1 (https=) |
| BR (1) | BR112021010645A2 (https=) |
| CA (1) | CA3121422A1 (https=) |
| IL (1) | IL283687A (https=) |
| MX (1) | MX2021006542A (https=) |
| SG (1) | SG11202105911PA (https=) |
| WO (1) | WO2020115500A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3965749A4 (en) * | 2019-05-06 | 2023-06-21 | Valo Health, Inc. | ESCAPEMENT OF USP19 |
| GB202104097D0 (en) | 2021-03-24 | 2021-05-05 | Almac Discovery Ltd | Pharmaceutical compounds |
| GB202311227D0 (en) | 2023-07-21 | 2023-09-06 | Almac Discovery Ltd | Pharmaceutical compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO111096A0 (en) * | 1996-07-18 | 1996-08-08 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| TW200930713A (en) | 2007-12-03 | 2009-07-16 | Takeda Pharmaceutical | Nitrogen-containing heterocyclic compound and use thereof |
| CN104174021A (zh) * | 2013-05-22 | 2014-12-03 | 复旦大学附属华山医院 | 蛋白酶体抑制剂在制备治疗慢性低度炎症性疾病药物中的用途 |
| AR103297A1 (es) * | 2014-12-30 | 2017-05-03 | Forma Therapeutics Inc | Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina |
| GB201612938D0 (en) * | 2016-07-26 | 2016-09-07 | Almac Discovery Ltd | Pharmaceutical compounds |
| CA3072353A1 (en) * | 2017-09-26 | 2019-04-04 | Dana-Farber Cancer Institute, Inc. | Usp7 inhibitors for treating multiple myeloma |
| GB201801562D0 (en) * | 2018-01-31 | 2018-03-14 | Almac Diagnostics Ltd | Pharmaceutical compounds |
-
2019
- 2019-12-06 MX MX2021006542A patent/MX2021006542A/es unknown
- 2019-12-06 US US17/299,971 patent/US20220016115A1/en not_active Abandoned
- 2019-12-06 SG SG11202105911PA patent/SG11202105911PA/en unknown
- 2019-12-06 EP EP19821175.7A patent/EP3890737B1/en active Active
- 2019-12-06 CA CA3121422A patent/CA3121422A1/en active Pending
- 2019-12-06 BR BR112021010645-6A patent/BR112021010645A2/pt not_active IP Right Cessation
- 2019-12-06 WO PCT/GB2019/053456 patent/WO2020115500A1/en not_active Ceased
- 2019-12-06 KR KR1020217019978A patent/KR20210100127A/ko not_active Withdrawn
- 2019-12-06 AU AU2019393161A patent/AU2019393161A1/en not_active Abandoned
- 2019-12-06 CN CN201980091404.7A patent/CN113395965A/zh active Pending
- 2019-12-06 JP JP2021532119A patent/JP2022510700A/ja active Pending
-
2021
- 2021-06-03 IL IL283687A patent/IL283687A/en unknown